Randomized Controlled Trial of Acupuncture for Functional Dyspepsia

Conditions

Functional Dyspepsia

Keywords

acupuncture, meridian, acupoint

Brief summary

The purpose of the study is to testify the efficacy of treating functional dyspepsia with acupuncture, and provide evidence for the hypothesis that Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point.

Detailed description

The purpose of the study is to testify whether acupuncture is effective for functional dyspepsia, through treating functional dyspepsia patient for a month, using different acupoints according to literatures of treating migraine with acupuncture, and using Itopride as controlled group, and try to provide clinical evidence for the hypothesis thatAcupuncture effect is based on meridians, and gathering of meridian Qi is the key point.

Ma T, Zeng F, Li Y, Wang CM, Tian X, Yu S, Zhao L, Wu X, Yang M, Wang D, Liang F.

2015-03-1117 citations

10.1159/000380983

Adverse events associated with acupuncture: three multicentre randomized controlled trials of 1968 cases in China.

Zhao L, Zhang FW, Li Y, Wu X, Zheng H, Cheng LH, Liang FR.

2011-03-2450 citations

10.1186/1745-6215-12-87

Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial.

Zheng H, Tian XP, Li Y, Liang FR, Yu SG, Liu XG, Tang Y, Yang XG, Yan J, Sun GJ, Chang XR, Zhang HX, Ma TT, Yu SY.

2009-08-2311 citations

10.1186/1745-6215-10-75

Papers published before 2008-02-04 may not appear yet. Historical indexing is in progress.

Interventions

OTHERacupuncture

Subjects are treated five days a week continuously, and for four weeks.They are treated 30min every time.

DRUGItopride

Each pill weighs 50mg, once a pill, three times a day. The pills are taken half an hour before meals, and be taken 4 weeks continuously.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

No

Inclusion criteria

1. Consistent with the diagnostic criteria of functional dyspepsia. 2. Age of a subject is older than 18 and is younger than 65.（including 18 and 65） 3. Did not take any gastroenteric dynamic drugs in the last 15 days, and did not take part in any clinical trial. 4. Informed consent is signed by a subject or his lineal relation.

Exclusion criteria

1. Patients with any contraindications of Itopride. 2. Patients who are unconscious, psychotic. 3. Patients with aggravating tumor and other serious consumptive disease, and who are subject to infection and bleeding. 4. With serious protopathy or disease of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on. 5. Pregnant women or women in lactation.

Design outcomes

Primary

Measure	Time frame
Nepean Dyspepsia Index	4 weeks

Secondary

Measure	Time frame
Symptoms Index of Dyspepsia	4 weeks

Countries

China

Outcome results

None listed